Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies
about
Development of a highly-potent anti-angiogenic VEGF8-109 heterodimer by directed blocking of its VEGFR-2 binding siteCurrent targeted therapies in the treatment of advanced colorectal cancer: a reviewTuning cell migration: contractility as an integrator of intracellular signals from multiple cuesNew perspectives in glioblastoma antiangiogenic therapyAntiangiogenic mechanisms and factors in breast cancer treatmentThe era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapyAnti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamineSpotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to dateSystemic therapy for advanced hepatocellular carcinoma: an update.Opioids: Modulators of angiogenesis in wound healing and cancer.Role of inflammation in previously untreated macular edema with branch retinal vein occlusionVascular endothelial growth factor signaling in hypoxia and inflammation.Overexpression of both platelet-derived growth factor-BB and vascular endothelial growth factor-C and its association with lymphangiogenesis in primary human non-small cell lung cancerVEGFR-1 blockade disrupts peri-implantation decidual angiogenesis and macrophage recruitmentSynergic antitumor effect of SKLB1002 and local hyperthermia in 4T1 and CT26.Effects of tetrahydrocurcumin on hypoxia-inducible factor-1α and vascular endothelial growth factor expression in cervical cancer cell-induced angiogenesis in nude mice.Junctional adhesion molecule-A regulates vascular endothelial growth factor receptor-2 signaling-dependent mouse corneal wound healing.Control of angiogenesis dictated by picomolar superoxide levels.In vitro evaluation of optimized liposomes for delivery of small interfering RNA.A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.Biochemically engineered stromal cell-derived factor 1-alpha analog increases perfusion in the ischemic hind limb.VEGF Gene Polymorphisms Affect Serum Protein Levels and Alter Disease Activity and Synovial Lesions in Rheumatoid ArthritisDiabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema.Functional-morphological parameters, aqueous flare and cytokines in macular oedema with branch retinal vein occlusion after ranibizumab.Vascular endothelial growth factor (VEGFA) gene variation in polycystic ovary syndrome in a Tunisian women population.EGF-Induced VEGF Exerts a PI3K-Dependent Positive Feedback on ERK and AKT through VEGFR2 in Hematological In Vitro Models.Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapy.Enzymatically-responsive pro-angiogenic peptide-releasing poly(ethylene glycol) hydrogels promote vascularization in vivoTargeted therapy in gastroesophageal cancers: past, present and future.Neuropeptide Y3-36 incorporated into PVAX nanoparticle improves functional blood flow in a murine model of hind limb ischemia.Priorities and trends in the study of proteins in eye research, 1924-2014Melittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinomaMicroRNA control of vascular endothelial growth factor signaling output during vascular development.Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.Serum vascular endothelial growth factor receptor-2 and adropin levels in age-related macular degenerationQuinazoline derivative compound (11d) as a novel angiogenesis inhibitor inhibiting VEGFR2 and blocking VEGFR2-mediated Akt/mTOR /p70s6k signaling pathwayAngiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.Discovery of pan-VEGF inhibitory peptides directed to the extracellular ligand-binding domains of the VEGF receptors.Neuronal sFlt1 and Vegfaa determine venous sprouting and spinal cord vascularization.
P2860
Q24302190-F633AABE-3880-4DF0-9033-E1B307950641Q26740067-94E75700-56B3-400C-802F-F24686211F7FQ26742035-DCDBEEE9-7315-4F74-ACEE-368F0959C8EEQ26746028-1E8C6256-3816-44AF-881B-5E14BF92B834Q26751226-FD650ED5-AA80-4C55-98CB-D1D3CBA4A5E3Q28067341-02FDE99E-53A1-4668-8140-2D2A39FD441AQ28488021-4360E55C-B57E-4391-BC94-5C0AA8D25E38Q33563281-5C4540D1-7ABD-42EE-9081-ECA18DC74725Q33593213-4B44E3B6-A7CE-40F9-8AC7-E9694EEF1592Q33649031-FE143A8B-CBD2-415F-99FA-3CA8E9E351D2Q33656127-38B6761C-CBD5-41EA-87C4-E080A3E2EB20Q33721685-96B65B2D-D571-4986-976F-FFDF7108702BQ33859145-8D0227C2-4985-4DBC-AA16-989285EA285DQ34006189-CB07E359-B540-4210-9CB3-4E28B636DBA1Q34521999-594A63C2-F942-4BB2-9E83-6C63FFA8CED9Q34668740-BC3BE845-9B17-4E1E-8D2C-5336EEDE43D4Q34718345-1BAF01C2-AB05-4C44-A68B-7FDFADE3464EQ34727974-CF621F87-2BAC-4580-AE33-48F8E5A76164Q35140847-BF6DFB25-CB6C-4CC3-BD0D-95C68404DEB0Q35695806-F2B4B0C8-3ED3-4887-ACB7-A8E2832FCEF6Q35776071-A8563B7D-4B52-4C8F-898D-90EE1B7FAFBEQ35908621-713E5266-0F42-4437-9C34-7B13E828E721Q35975239-37E57F45-DF5B-41CC-90D1-1538B77EE9A2Q35988002-3BC5AA89-20F5-41A1-B529-224BA0B7F427Q36170306-1C238318-D8FB-4123-95C4-602E0E0F1E9AQ36180362-F887989C-F552-456F-B56B-6245F01B9EACQ36193664-A0EE4EF5-477C-4BF9-9E8F-45EACEDB0733Q36212825-0BAB8261-0DCB-4784-A8F8-D63EEEEA6604Q36225041-7B6C320C-E84B-4ED9-9A2F-AE376DBE6535Q36294579-CC43A8AB-A60E-4E2B-B1CC-66E52B746C0BQ36311441-7D092119-394C-45F3-84E2-F55E3B883A19Q36414959-120B8188-252C-42C5-AD32-F9C3CD6A2F0FQ36502706-A0F3CDEE-7BE2-4BBC-B27D-75A57307E4BDQ36554547-1AF5903D-F404-425B-8DD3-D1EB81B3770CQ36803294-E607D112-8E3C-4B09-A874-614997244615Q36858963-6081CC5F-C184-4334-84F9-E6615ECA215DQ36953182-D4332E03-0D7A-4214-A7DE-B52741AA8DABQ37315498-0ABDCFA0-9729-4E6A-BD2E-9630BA8FE7B1Q37388064-5B300ED3-87E9-47FB-80BE-93BDB84769E8Q37584778-AEC923D2-D09F-44FB-969A-2288D9EF9A01
P2860
Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Vascular Endothelial Growth Fa ...... - and Pro-Angiogenic Therapies
@ast
Vascular Endothelial Growth Fa ...... - and Pro-Angiogenic Therapies
@en
type
label
Vascular Endothelial Growth Fa ...... - and Pro-Angiogenic Therapies
@ast
Vascular Endothelial Growth Fa ...... - and Pro-Angiogenic Therapies
@en
prefLabel
Vascular Endothelial Growth Fa ...... - and Pro-Angiogenic Therapies
@ast
Vascular Endothelial Growth Fa ...... - and Pro-Angiogenic Therapies
@en
P2860
P356
P1433
P1476
Vascular Endothelial Growth Fa ...... - and Pro-Angiogenic Therapies
@en
P2093
Masabumi Shibuya
P2860
P304
P356
10.1177/1947601911423031
P577
2011-12-01T00:00:00Z